# Dekkun Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dekkun

- Industry: Pharmaceuticals
- Headquarters: Cambridge, US
- Total disclosed funding: $7M
- Latest round: Series B (Jan 3, 2011)
- Investors on record: 1

## About

Dekkun Corporation develops pharmaceutical technologies. It offers humanized antibodies for the treatment of bone fractures and oncology.

## Funding rounds

- Series B, Jan 3, 2011, $7M — HealthCare Ventures

## Investors

- HealthCare Ventures — Series B
